2025-2034 Quinolones Market Roadmap: Insights for Competitive Advantage

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

How Large Will the Quinolones Market Size By 2025?
In recent times, the size of the quinolones market has seen consistent growth. The market is projected to expand from $50.05 billion in 2024 to $51.89 billion in 2025, experiencing a compound annual growth rate (CAGR) of 3.7%. Factors such as the demand and use of antibiotics, regulatory approvals, research and development, market competition, and patent expiry dates have contributed to the growth during the historic period.

How Big Is the Quinolones Market Size Expected to Grow by 2029?
The quinolones market is predicted to witness robust growth in the coming years, expanding to "$63.17 billion in 2029" at a compound annual growth rate (CAGR) of 5.0%. Factors contributing to the growth during the forecast period may include new diseases, modifications in regulations, worldwide health strategies, an increase in antibiotic resistance, and strategies for market enlargement. The forecast period is also expected to see significant trends like the development of new products and shifts in regulatory frameworks.

View the full report here:
https://www.thebusinessresearchcompany.com/report/quinolones-global-market-report

Which Key Market Drivers Powering Quinolones Market Expansion and Growth?
The quinolones market is experiencing significant growth due to the increasing prevalence of infectious diseases. Such diseases are caused by microorganisms including parasites, fungi, bacteria, and viruses, with quinolones serving as a common treatment for bacterial infections like tuberculosis and urinary tract infections. For example, data from the Global Tuberculosis Report by the World Health Organization, a health agency based in Switzerland, noted that the global number of newly identified TB cases surged to 7.5 million in 2022, up from 6.4 million in 2021. As such, the escalating occurrence of infectious diseases is propelling the quinolones market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9429&type=smp

Which Fast-Growing Trends Are Poised to Disrupt the Quinolones Market?
Product innovation is becoming increasingly prominent as a trend within the quinolones market. Leading businesses in this sector are concentrating their efforts on pioneering new products to maintain their standing in the market. For example, in January 2023, Viatris, which is an American pharmaceutical company that has its branch in South Korea, introduced Dovprela. This is a novel treatment for drug-resistant tuberculosis, consisting of a three-drug regime of bedaquiline, pretomanid, and linezolid (BPaL). The treatment is intended for adult patients who are dealing with extensively drug-resistant TB or multidrug-resistant TB that isn't responding to treatment. Compared to the standard 18-20 month treatment period, Dovprela cuts down the recovery period to 5-6 months, thanks to its rapid anti-tuberculosis effect.

What Are the Emerging Segments in the Quinolones Market?
The quinolones market covered in this report is segmented -

1) By Type: Norfloxacin, Ofloxacin, Ciprofloxacin, Gemifloxacin, Other Types
2) By Pathogen Type: Gram-Positive Pathogen, Gram-Negative Pathogen
3) By Application: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Subsegments:
1) By Norfloxacin: Indications, Dosage Forms
2) By Ofloxacin: Indications, Dosage Forms
3) By Ciprofloxacin: Indications, Dosage Forms
4) By Gemifloxacin: Indications, Dosage Forms
5) By Other Types: Various Formulations, Indications

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=9429&type=smp

Who Are the Global Leaders in the Quinolones Market?
Major companies operating in the quinolones market include Bayer AG, Novartis AG, Sanofi SA, Merck & Co. Inc., LG Life Sciences, Pfizer Inc., Viatris Inc., Lupin Limited, Hikma Pharmaceuticals plc, Zydus Group, KYORIN Holdings Inc., Teva Pharmaceutical Industries Ltd., GSK plc, Zee Laboratories, Cipla Ltd., Geo Pharma Pvt. Ltd., Finecure Pharmaceuticals, Novus, AstraZeneca plc, Sun Pharmaceutical Industries Ltd., Dr. Reddy's Laboratories Ltd., Cadila Healthcare Ltd., Glenmark Pharmaceuticals Ltd., Alkem Laboratories Ltd., Torrent Pharmaceuticals Ltd., Macleods Pharmaceuticals Ltd., Alembic Pharmaceuticals Ltd., Hetero Drugs Ltd., Wockhardt Ltd.

Which are the Top Profitable Regional Markets for the Quinolones Industry?
North America was the largest region in the quinolones market in 2024. The regions covered in the quinolones market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9429

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.